Spok Holdings Inc (SPOK)

$14.58

+0.2

(+1.39%)▲

Market is closed - opens 7 PM, 28 Sep 2023

Insights on Spok Holdings Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 33.18M → 36.46M (in $), with an average increase of 9.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 24.22M → 4.73M (in $), with an average decrease of 51.7% per quarter

Performance

  • $14.27
    $14.84
    $14.58
    downward going graph

    2.1%

    Downside

    Day's Volatility :3.82%

    Upside

    1.75%

    downward going graph
  • $6.29
    $15.97
    $14.58
    downward going graph

    56.86%

    Downside

    52 Weeks Volatility :60.61%

    Upside

    8.7%

    downward going graph

Returns

PeriodSpok Holdings IncSector (Communication Services)Index (Russel 2000)
3 Months
12.5%
0.7%
0.0%
6 Months
45.95%
16.7%
0.9%
1 Year
96.23%
31.3%
3.1%
3 Years
55.6%
10.0%
17.1%

Highlights

Market Capitalization
287.1M
Book Value
$8.35
Dividend Share
1.25
Dividend Yield
8.69%
Earnings Per Share (EPS)
1.75
PE Ratio
8.22
PEG Ratio
0.0
Wall Street Target Price
15.5
Profit Margin
25.61%
Operating Margin TTM
14.58%
Return On Assets TTM
5.38%
Return On Equity TTM
21.68%
Revenue TTM
136.6M
Revenue Per Share TTM
6.9
Quarterly Revenue Growth YOY
8.200000000000001%
Gross Profit TTM
90.8M
EBITDA
24.2M
Diluted Eps TTM
1.75
Quarterly Earnings Growth YOY
1.35
EPS Estimate Current Year
0.86
EPS Estimate Next Year
0.95
EPS Estimate Current Quarter
0.23
EPS Estimate Next Quarter
0.24

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Spok Holdings Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 6.31%

Current $14.58
Target $15.50

Company Financials

FY17Y/Y Change
Revenue
171.2M
↓ 4.67%
Net Income
-15.3M
↓ 209.49%
Net Profit Margin
-8.94%
↓ 16.73%
FY18Y/Y Change
Revenue
169.5M
↓ 0.99%
Net Income
-1.5M
↓ 90.34%
Net Profit Margin
-0.87%
↑ 8.07%
FY19Y/Y Change
Revenue
160.3M
↓ 5.42%
Net Income
-10.8M
↑ 627.86%
Net Profit Margin
-6.72%
↓ 5.85%
FY20Y/Y Change
Revenue
148.2M
↓ 7.55%
Net Income
-44.2M
↑ 310.82%
Net Profit Margin
-29.85%
↓ 23.13%
FY21Y/Y Change
Revenue
142.2M
↓ 4.07%
Net Income
-22.2M
↓ 49.85%
Net Profit Margin
-15.6%
↑ 14.25%
FY22Y/Y Change
Revenue
134.5M
↓ 5.36%
Net Income
21.9M
↓ 198.54%
Net Profit Margin
16.25%
↑ 31.85%
Q1 FY22Q/Q Change
Revenue
33.8M
↓ 2.08%
Net Income
-7.2M
↓ 56.72%
Net Profit Margin
-21.33%
↑ 26.93%
Q2 FY22Q/Q Change
Revenue
33.7M
↓ 0.34%
Net Income
1.9M
↓ 126.67%
Net Profit Margin
5.71%
↑ 27.04%
Q3 FY22Q/Q Change
Revenue
33.7M
↑ 0.1%
Net Income
2.9M
↑ 51.77%
Net Profit Margin
8.65%
↑ 2.94%
Q4 FY22Q/Q Change
Revenue
33.3M
↓ 1.45%
Net Income
24.2M
↑ 729.66%
Net Profit Margin
72.85%
↑ 64.2%
Q1 FY23Q/Q Change
Revenue
33.2M
↓ 0.23%
Net Income
7.0M
↓ 71.24%
Net Profit Margin
21.0%
↓ 51.85%
Q2 FY23Q/Q Change
Revenue
36.5M
↑ 9.89%
Net Income
4.7M
↓ 32.07%
Net Profit Margin
12.98%
↓ 8.02%
FY17Y/Y Change
Total Assets
350.6M
↓ 9.67%
Total Liabilities
60.0M
↓ 9.04%
FY18Y/Y Change
Total Assets
327.7M
↓ 6.52%
Total Liabilities
53.2M
↓ 11.45%
FY19Y/Y Change
Total Assets
319.9M
↓ 2.39%
Total Liabilities
69.8M
↑ 31.27%
FY20Y/Y Change
Total Assets
277.3M
↓ 13.31%
Total Liabilities
76.7M
↑ 9.89%
FY21Y/Y Change
Total Assets
248.2M
↓ 10.51%
Total Liabilities
74.5M
↓ 2.89%
FY22Y/Y Change
Total Assets
244.5M
↓ 1.48%
Total Liabilities
72.4M
↓ 2.77%
Q1 FY22Q/Q Change
Total Assets
232.9M
↓ 6.16%
Total Liabilities
73.0M
↓ 1.99%
Q2 FY22Q/Q Change
Total Assets
228.9M
↓ 1.72%
Total Liabilities
72.7M
↓ 0.41%
Q3 FY22Q/Q Change
Total Assets
226.5M
↓ 1.02%
Total Liabilities
73.3M
↑ 0.82%
Q4 FY22Q/Q Change
Total Assets
244.5M
↑ 7.92%
Total Liabilities
72.4M
↓ 1.2%
Q1 FY23Q/Q Change
Total Assets
231.8M
↓ 5.21%
Total Liabilities
63.4M
↓ 12.43%
Q2 FY23Q/Q Change
Total Assets
233.9M
↑ 0.94%
Total Liabilities
67.3M
↑ 6.17%
FY17Y/Y Change
Operating Cash Flow
15.6M
↓ 58.47%
Investing Cash Flow
-9.2M
↑ 11.97%
Financing Cash Flow
-25.0M
↑ 49.5%
FY18Y/Y Change
Operating Cash Flow
10.3M
↓ 33.69%
Investing Cash Flow
-5.8M
↓ 36.77%
Financing Cash Flow
-24.3M
↓ 2.9%
FY19Y/Y Change
Operating Cash Flow
11.7M
↑ 13.36%
Investing Cash Flow
-30.2M
↑ 418.74%
Financing Cash Flow
-17.2M
↓ 29.34%
FY20Y/Y Change
Operating Cash Flow
26.2M
↑ 123.75%
Investing Cash Flow
-14.6M
↓ 51.79%
Financing Cash Flow
-10.4M
↓ 39.53%
FY21Y/Y Change
Operating Cash Flow
8.0M
↓ 69.54%
Investing Cash Flow
-225.0K
↓ 98.46%
Financing Cash Flow
-11.8M
↑ 13.3%
Q1 FY22Q/Q Change
Operating Cash Flow
-4.9M
↑ 212.76%
Investing Cash Flow
-646.0K
↓ 105.82%
Financing Cash Flow
-7.7M
↑ 217.58%
Q2 FY22Q/Q Change
Operating Cash Flow
-1.0M
↓ 79.18%
Investing Cash Flow
-513.0K
↓ 20.59%
Financing Cash Flow
-6.2M
↓ 20.41%
Q3 FY22Q/Q Change
Operating Cash Flow
5.7M
↓ 665.65%
Investing Cash Flow
14.4M
↓ 2910.72%
Financing Cash Flow
-6.2M
↑ 0.24%
Q2 FY23Q/Q Change
Operating Cash Flow
8.6M
↑ 228.88%
Investing Cash Flow
-1.2M
-
Financing Cash Flow
-6.1M
↓ 24.92%

Technicals Summary

Sell

Neutral

Buy

Spok Holdings Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Spok Holdings Inc
Spok Holdings Inc
1.96%
45.95%
96.23%
55.6%
-5.32%
10x Genomics Inc
10x Genomics Inc
-12.6%
-15.56%
30.42%
-66.92%
-21.73%
Veeva Systems Inc.
Veeva Systems Inc.
6.01%
14.96%
22.54%
-28.41%
85.4%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-1.49%
-11.21%
12.88%
12.88%
12.88%
Healthequity Inc
Healthequity Inc
11.26%
31.53%
7.08%
52.65%
-19.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Spok Holdings Inc
Spok Holdings Inc
8.22
8.22
0.0
0.86
0.22
0.05
0.09
8.35
10x Genomics Inc
10x Genomics Inc
NA
NA
NA
-1.69
-0.22
-0.11
0.0
6.76
Veeva Systems Inc.
Veeva Systems Inc.
61.35
61.35
1.27
4.18
0.15
0.05
0.0
25.85
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
19.51
19.51
NA
3.8
0.15
0.06
0.0
15.62
Healthequity Inc
Healthequity Inc
493.33
493.33
1.92
1.33
0.01
0.02
0.0
22.77
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Spok Holdings Inc
Spok Holdings Inc
Buy
$287.1M
-5.32%
8.22
25.61%
10x Genomics Inc
10x Genomics Inc
Buy
$6.3B
-21.73%
NA
-30.31%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.0B
85.4%
61.35
24.2%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$31.5B
12.88%
19.51
9.62%
Healthequity Inc
Healthequity Inc
Buy
$6.3B
-19.93%
493.33
1.37%

Institutional Holdings

  • BlackRock Inc

    6.16%

  • Renaissance Technologies Corp

    6.00%

  • Vanguard Group Inc

    4.68%

  • Dimensional Fund Advisors, Inc.

    4.08%

  • HighTower Advisors, LLC

    2.78%

  • Foundry Partners, LLC

    2.27%

Corporate Announcements

  • Spok Holdings Inc Dividends March,2023

    In the quarter ending March,2023. Spok Holdings Inc has declared dividend of $0.31

    Read More

Company Information

spok, inc., a wholly owned subsidiary of spok holdings, inc. (nasdaq: spok), headquartered in springfield, va., is proud to be the global leader in healthcare communications. we deliver clinical information to care teams when and where it matters most to improve patient outcomes. top hospitals rely on the spok care connect® platform to enhance workflows for clinicians, support administrative compliance, and provide a better experience for patients. our customers send over 100 million messages each month through their spok® solutions. when seconds count, count on spok. for more information, visit spok.com or follow @spoktweets on twitter.

Organization
Spok Holdings Inc
Employees
382
CEO
Mr. Vincent D. Kelly
Industry
Communications

Discover More

FAQs